HUMAN PHOTOSYNTHESIS - Trademark Details
Status: 702 - Section 8 & 15-Accepted And Acknowledged
Serial Number
77748311
Registration Number
4478337
Word Mark
HUMAN PHOTOSYNTHESIS
Status
702 - Section 8 & 15-Accepted And Acknowledged
Status Date
2020-02-21
Filing Date
2009-05-30
Registration Number
4478337
Registration Date
2014-02-04
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2010-04-27
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
CHANG, KATHERINE S
Statements
Disclaimer with Predetermined Text
"HUMAN"
Goods and Services
Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Homeopathic pharmaceuticals for smoking cessation; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with nicotine for smoking cessation; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti- infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of arthritis, Alzheimer's disease, Parkinson's disease; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, psychotropics; Plant extracts for medical, veterinary and pharmaceutical purposes; Therapeutic pharmaceutical for smoking cessation
Goods and Services
Pharmaceutical advice
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2009-06-03
Primary Code
005
First Use Anywhere Date
2005-06-11
First Use In Commerce Date
2013-01-25
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Bridget H. Labutta
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2009-06-03 | NEW APPLICATION ENTERED IN TRAM |
2009-06-03 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2009-08-31 | ASSIGNED TO EXAMINER |
2009-09-03 | NON-FINAL ACTION WRITTEN |
2009-09-03 | NON-FINAL ACTION E-MAILED |
2009-09-03 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2010-03-03 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2010-03-16 | ASSIGNED TO LIE |
2010-03-16 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2010-03-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2010-03-17 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2010-03-22 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2010-04-07 | NOTICE OF PUBLICATION |
2010-04-27 | PUBLISHED FOR OPPOSITION |
2010-06-22 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
2010-12-22 | TEAS EXTENSION RECEIVED |
2011-01-21 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2010-12-22 | EXTENSION 1 FILED |
2011-01-21 | EXTENSION 1 GRANTED |
2011-01-22 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
2011-06-22 | TEAS EXTENSION RECEIVED |
2011-06-22 | EXTENSION 2 FILED |
2011-06-24 | EXTENSION 2 GRANTED |
2011-06-25 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
2011-12-22 | TEAS EXTENSION RECEIVED |
2011-12-22 | EXTENSION 3 FILED |
2012-01-03 | EXTENSION 3 GRANTED |
2012-01-04 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
2012-02-01 | UNDELIVERABLE MAIL - NO ACTION TAKEN |
2012-04-24 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2012-06-19 | TEAS EXTENSION RECEIVED |
2012-06-19 | EXTENSION 4 FILED |
2012-06-20 | EXTENSION 4 GRANTED |
2012-06-21 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2012-12-31 | PAPER RECEIVED |
2012-12-22 | EXTENSION 5 FILED |
2013-01-09 | EXTENSION 5 GRANTED |
2013-01-10 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2013-06-24 | TEAS STATEMENT OF USE RECEIVED |
2013-06-22 | USE AMENDMENT FILED |
2013-06-26 | STATEMENT OF USE PROCESSING COMPLETE |
2013-07-02 | SU - NON-FINAL ACTION - WRITTEN |
2013-07-02 | NON-FINAL ACTION E-MAILED |
2013-07-02 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2013-07-02 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2013-07-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2013-07-09 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2013-07-09 | SU - FINAL REFUSAL - WRITTEN |
2013-07-09 | FINAL REFUSAL E-MAILED |
2013-07-09 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2013-12-19 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2013-12-19 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2013-12-19 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2013-12-20 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2013-12-31 | LAW OFFICE REGISTRATION REVIEW COMPLETED |
2014-01-01 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
2014-01-28 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2014-01-28 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2014-02-04 | REGISTERED-PRINCIPAL REGISTER |
2016-02-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2016-02-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2019-02-04 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
2019-12-20 | TEAS SECTION 8 & 15 RECEIVED |
2020-02-21 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2020-02-21 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
2020-02-21 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |